Targeting ROS-induced osteoblast senescence and RANKL production by Prussian blue nanozyme based gene editing platform to reverse osteoporosis
- Resource Type
- Source
- Nano Today. 50:101839
- Subject
Biomedical Engineering Pharmaceutical Science General Materials Science Bioengineering Biotechnology - Language
- ISSN
- 1748-0132